Form 8-K - Current report:
SEC Accession No. 0001279569-22-000861
Filing Date
2022-05-24
Accepted
2022-05-24 10:19:52
Documents
14
Period of Report
2022-05-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 30061
2 NEWS RELEASE DATED MAY 23, 2022 ex991.htm EX-99.1 100140
3 GRAPHIC logo.jpg GRAPHIC 2698
  Complete submission text file 0001279569-22-000861.txt   322723

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ffntf-20220523.xsd EX-101.SCH 3038
5 XBRL LABEL FILE ffntf-20220523_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ffntf-20220523_pre.xml EX-101.PRE 22372
8 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3756
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 22954438
SIC: 2833 Medicinal Chemicals & Botanical Products